First Time Loading...

Eisai Co Ltd
TSE:4523

Watchlist Manager
Eisai Co Ltd Logo
Eisai Co Ltd
TSE:4523
Watchlist
Price: 6 545 JPY -0.06% Market Closed
Updated: May 2, 2024
Section:
 

Relative Value

The Relative Value of one Eisai Co Ltd stock under the Base Case scenario is 9 218.47 JPY. Compared to the current market price of 6 545 JPY, Eisai Co Ltd is Undervalued by 29%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
9 218.47 JPY
Undervaluation 29%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

2.5
P/S
P/S
Price to Sales
2.5
vs History
76
vs Industry
46
Median 3Y
2.9
Median 5Y
3
Industry
2.4
Forward
2.5
More Details
41.4
P/E
P/E
Price to Earnings
41.4
vs History
36
vs Industry
11
Median 3Y
46
Median 5Y
36.4
Industry
22.9
Forward
45
More Details
30.3
P/OCF
P/OCF
Price to OCF
30.3
vs History
31
vs Industry
15
Median 3Y
28.2
Median 5Y
22.1
Industry
17.1
More Details
45.6
P/FCFE
P/FCFE
Price to FCFE
45.6
vs History
41
vs Industry
13
Median 3Y
43.3
Median 5Y
42.4
Industry
23.2
More Details
2.3
P/B
P/B
Price to Book Value
2.3
vs History
80
vs Industry
36
Median 3Y
2.7
Median 5Y
2.8
Industry
2.1
More Details
2.3
EV/S
EV/S
Enterprise Value to Sales
2.3
vs History
71
vs Industry
48
Median 3Y
2.7
Median 5Y
2.8
Industry
2.6
Forward
2.3
More Details
2.9
EV/GP
EV/GP
Enterprise Value to Gross Profit
2.9
vs History
76
vs Industry
63
Median 3Y
3.6
Median 5Y
3.6
Industry
5.1
More Details
16.4
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
16.4
vs History
47
vs Industry
24
Median 3Y
20.2
Median 5Y
16.1
Industry
13.6
Forward
18.8
More Details
26.2
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
26.2
vs History
38
vs Industry
17
Median 3Y
29.5
Median 5Y
23.5
Industry
17
Forward
34.6
More Details
27.9
EV/OCF
EV/OCF
Enterprise Value to OCF
27.9
vs History
31
vs Industry
17
Median 3Y
25.8
Median 5Y
20.2
Industry
15.8
More Details
48.4
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
48.4
vs History
26
vs Industry
11
Median 3Y
18.1
Median 5Y
26.6
Industry
17.6
More Details
1.8
EV/IC
EV/IC
Enterprise Value to IC
1.8
vs History
77
vs Industry
41
Median 3Y
2.2
Median 5Y
2.3
Industry
1.9
More Details

Multiples Across Competitors

Competitors Multiples
Eisai Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
JP
Eisai Co Ltd
TSE:4523
1.9T JPY 2.5 41.4 16.4 26.2
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
724.1B USD 21.2 138.2 62.4 71.6
DK
Novo Nordisk A/S
CSE:NOVO B
3.9T DKK 16.9 46.8 34.2 37.3
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
359.6B USD 4.4 8.9 11.8 15.6
US
Merck & Co Inc
NYSE:MRK
326.2B USD 5.3 141.5 33.6 53.4
UK
AstraZeneca PLC
LSE:AZN
188.4B GBP 5.1 39.5 140.7 225.8
CH
Novartis AG
SIX:NOVN
181.6B CHF 4.2 13.3 9.8 16.1
CH
Roche Holding AG
SIX:ROG
170.6B CHF 2.9 14.8 8.5 10.1
US
Pfizer Inc
NYSE:PFE
155.3B USD 2.7 73.3 10.9 16.2
P/E Multiple
Earnings Growth
JP
Eisai Co Ltd
TSE:4523
Average P/E: 57.5
41.4
31%
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
138.2
346%
DK
Novo Nordisk A/S
CSE:NOVO B
46.8
84%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
US
Johnson & Johnson
NYSE:JNJ
8.9
-20%
US
Merck & Co Inc
NYSE:MRK
141.5
7 454%
UK
AstraZeneca PLC
LSE:AZN
39.5
168%
CH
Novartis AG
SIX:NOVN
13.3
15%
CH
Roche Holding AG
SIX:ROG
14.8
26%
US
Pfizer Inc
NYSE:PFE
73.3
680%

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 133,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.